F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile

Document Sample
F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile Powered By Docstoc
					        F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances
                                         Profile
       Reference Code: GDME756D                                                                                                                  Publication Date: MAR 2013

      Company Overview                                                                                          Key Facts
      F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company. It
                                                                                                                F. Hoffmann-La Roche Ltd., Medical Equipment,
      discovers, develops, manufactures and markets innovative diagnostics and
                                                                                                                Key Facts, 2012
      therapeutic products and services. The company classified its operations into two
      reportable business segments, namely, Pharmaceuticals and Diagnostics. Roche's                             Web Address                         www.roche.com
      products and services address the prevention, diagnosis and treatment of diseases,
                                                                                                                 Revenue (US$ million)                                       45,245.74
      and improve the well-being and quality of life of patients. Geographically, the
      company has operations in various countries across North America, Latin America,                           Number of Employees                                           82,089
      Europe and Asia. Roche is headquartered in Basel, Switzerland.                                             GlobalData

      Financial Deals Landscape
        F. Hoffmann-La Roche Ltd., Medical Equipment, Deals by Type,                       F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By
        2007 to YTD 2013                                                                   Year, 2007 to YTD 2013

                                                                                                           20
                                                                                                                                                              17
                                                                                                                   16
                                                                                                                                                     15



                                                                                            No. of Deals
                                                                                                           15                 13             13


                                                                                                           10
                                                                                                                                        6
                                                                                                           5                                                             2

                                                                                                           0
                                                                                                                  2007       2008   2009    2010    2011      2012   YTD
                                                                                                                                                                     2013


                                                                                           Note: Deals include all announced medical equipment deals from 2006
         Note: Deals include all announced medical equipment deals from 2006               onwards, GlobalData
         onwards, GlobalData


         F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By                            F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By
         Region, 2007 to YTD 2013                                                          Market, 2007 to YTD 2013

                         60                                                                                80           70
          No. of Deals




                                56       55
                                                                                            No. of Deals




                         40                                                                                60
                                                  23       22        19
                         20                                                                                40

                         0                                                                                 20
                              Europe   North    Asia-     Middle   South                                                            3        3            3          2
                                       Americ   Pacific    East     and                                    0
                                         a                 and     Central                                         In Vitro Diagno Health Special Diabete
                                                          Africa   Americ                                          Diagno     stic Care IT   ized   s Care
                                                                     a                                               stics Imagi…          Sectors D evic…



         Note: Deals include all announced medical equipment deals from 2006               Note: Deals include all announced medical equipment deals from 2006
         onwards, GlobalData                                                               onwards, GlobalData


        F. Hoffmann-La Roche Ltd., Medical Equipment, Deals Summary, 2007 to YTD 2013
        Year                                                     No. of Deals                                                               Deal Value (US$ million)
        2007                                                                                                             16                                                        810.30
        2008                                                                                                             13                                                       3,400.00
        2009                                                                                                              6                                                            NA
        2010                                                                                                             13                                                         301.78
        2011                                                                                                             15                                                         393.48
        2012                                                                                                             17                                                         660.81
        YTD 2013                                                                                                          2                                                            NA
        Note: Deals include all announced medical equipment deals from 2006 onwards, deal values included wherever disclosed, GlobalData




F. Hoffmann-La Roche Ltd. - Medical Equipment - Deals and                                                                                             Reference Code: GDME756D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                               Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 5
          List of Figures ................................................................................................................................................................................. 7
       F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By Year, 2007 to YTD 2013 ........................................................................ 8
       F. Hoffmann-La Roche Ltd., Medical Equipment Deals By Type, 2007 to YTD 2013......................................................................... 9
       F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By Region, 2007 to YTD 2013 .................................................................. 10
       F. Hoffmann-La Roche Ltd., Medical Equipment, Deals By Market, 2007 to YTD 2013................................................................... 11
       F. Hoffmann-La Roche Ltd., Medical Equipment, Deals Summary, 2007 to YTD 2013 ................................................................... 12
       F. Hoffmann-La Roche Ltd., Medical Equipment, Deal Details......................................................................................................... 19
          Venture Financing......................................................................................................................................................................... 19
             HistoRx Secures $6 Million In Series B Financing .................................................................................................................... 19
             Cylex Secures $20.5 Million In Series C Financing ................................................................................................................... 21
          Partnerships.................................................................................................................................................................................. 23
             Ventana Medical Systems Enters Into Licensing Agreement With Biocare Medical ................................................................. 23
             Ventana Medical Enters Into Licensing Agreement With German Cancer Research Center And University Hospital Heidelberg
             For BRAF V600E....................................................................................................................................................................... 25
             Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker .................................................... 27
             Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology............................................................ 28
             Ventana Medical Systems Enters Into Licensing Agreement With Cell Signaling Technology.................................................. 29
             Cell Signaling Technology Enters Into Licensing Agreement With Ventana Medical Systems.................................................. 30
             Circadian Technologies Enters Into Licensing Agreement With Chugai Pharma ...................................................................... 31
             Genentech And Roche Enter Into Licensing Agreement With ForSight VISION4 For Sustained Delivery Lucentis .................. 32
             Aposense Enters Into An Agreement With Roche..................................................................................................................... 33
             Alere Enters Into Licensing Agreement With Roche Diagnostics .............................................................................................. 34
             Roche Diagnostics Enters Into Licensing Agreement With Alere .............................................................................................. 35
             Roche Enters Into Licensing Agreement With QIAGEN ............................................................................................................ 36
             CMIC Signs Licensing Agreement With Roche ......................................................................................................................... 37
             Psynova Neurotech Enters Into Research And Licensing Agreement With Roche ................................................................... 38
             QIAGEN Enters Into An Agreement With Roche And Idaho Technology .................................................................................. 39
             Medizinische Hochschule Hannover Signs An Agreement With Roche Diagnostics................................................................. 40
             Fujirebio Diagnostics Enters Into An Agreement With Roche Diagnostics ................................................................................ 41
             Exiqon Signs An Agreement With Roche Diagnostics............................................................................................................... 42
             Roche Diagnostics Enters Into Licensing Agreement With Radiometer Medical....................................................................... 43
             Exiqon And Roche Diagnostics Enter Into Partnership ............................................................................................................. 44
             Amic Enters Into Licensing Agreement With Roche Diagnostics .............................................................................................. 45
             Roche Signs Licensing Agreement With Ortho-Clinical Diagnostics And Novartis Vaccines and Diagnostics .......................... 46
             Dade Behring And Roche Diagnostics Enter Into Licensing Agreement With DiaSorin ............................................................ 47
             Osmetech Licenses Hot Start Polymerase Technology From Roche ........................................................................................ 48
             QIAGEN Enters Into Licensing Agreement With Roche Diagnostics ........................................................................................ 49
             Roche Diagnostics Signs An Agreement With Multilyte ............................................................................................................ 50
             Roche Enters Into Co-Development Agreement With BioLamina For Cell Culture Systems..................................................... 51
             Roche Enters Into Co-Development Agreement With Precision System Science For PCR Instrument .................................... 52
             NCM USA Enters Into Co-Development Agreement With Genentech For Clinical Imaging Agents .......................................... 53
             Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA .......................................................................... 54
             Sysmex Extends Distribution Agreement With Roche ............................................................................................................... 55
             Seattle Genetics And Millennium Pharma Enter Into Co-Development Agreement With Ventana Medical Systems ................ 56

F. Hoffmann-La Roche Ltd. - Medical Equipment - Deals and                                                                                                              Reference Code: GDME756D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
             Roche Enters Into Co-Development Agreement With Technoclone .......................................................................................... 58
             Ventana Medical Systems Enters Into Co-Development Agreement With Bayer Pharma ........................................................ 59
             Ventana Medical Systems Enters Into Co-Development Agreement With Pfizer ...................................................................... 60
             Syndax Pharma Enters Into Co-Development Agreement With Ventana Medical Systems ...................................................... 61
             AEterna Zentaris Enters Into Co-Development Agreement With Ventana Medical Systems .................................................... 62
             Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University
             Hospital Zurich .......................................................................................................................................................................... 63
             Roche Enters Into Technology Integration Agreement With Labcyte ........................................................................................ 65
             Roche Enters Into Distribution Agreement With PerkinElmer.................................................................................................... 66
             Roche NimbleGen Enters Into Co-Marketing Agreement With Caliper Life Sciences ............................................................... 67
             Roche Enters Into Collaboration With Evotec ........................................................................................................................... 68
             University of Geneva, Hopitaux Universitaires de Geneve, SIB And Roche Form Partnership ................................................. 69
             F. Hoffmann-La Roche Enters Into Co-Development Agreement With Merck........................................................................... 70
             Roche Enters Into Co-Development Agreement With Clovis Oncology .................................................................................... 71
             RainDance Technologies Enters Into Collaboration With 454 Life Sciences............................................................................. 72
             Itamar Medical Signs Co-Development Agreement With F. Hoffmann-La Roche ..................................................................... 73
             Transgene Enters Into Collaboration With Ventana Medical Systems ...................................................................................... 74
             Clovis Oncology Enteres Into Co-Development Agreement With Ventana Medical Systems ................................................... 75
             OraSure Technologies Enters Into An Agreement With Roche Diagnostics ............................................................................. 76
             Fluofarma Enters Into Co-Development Agreement With Roche .............................................................................................. 77
             Dako Enters Into Collaboration Agreement With Genentech .................................................................................................... 78
             Roche Diagnostics Scandinavia Enters Into Co-Marketing Agreement With NorDiag .............................................................. 79
             Response Biomedical Signs An Agreement With Roche Diagnostics ....................................................................................... 80
             Roche Signs Distribution Agreement With DxS ......................................................................................................................... 81
             Mankind Pharma Enters Into An Agreement With Roche Diagnostics ...................................................................................... 82
             Roche Diagnostics Signs An Agreement With ARK Diagnostics............................................................................................... 83
             Ensemble Discovery Enters Into Research Collaboration With Roche...................................................................................... 84
             Sysmex Extends Distribution Agreement With Roche ............................................................................................................... 85
             Sysmex Enters Into Co-Marketing Agreement With Roche ....................................................................................................... 86
             Ventana Medical Enters Into An Agreement With Genentech ................................................................................................... 87
             Roche Diagnostics Enters Into Licensing Agreement With Arizona Technology And Columbia University............................... 88
             Eppendorf Enters Into Licensing Agreement With F. Hoffmann-La Roche................................................................................ 89
             F. Hoffmann-La Roche Enters Into Licensing Agreement With Genzyme ................................................................................. 90
             AsymmetRx Enters Into Licensing Agreement With Ventana Medical ...................................................................................... 91
             Takara Bio Signs Licensing Agreement With Roche Diagnostics ............................................................................................. 92
             Osmetech Enters Into Licensing Agreement With Roche.......................................................................................................... 93
             Roche Diagnostics Enters Into An Agreement With Eppendorf................................................................................................. 94
          Asset Transactions ....................................................................................................................................................................... 95
             SynenTec To Acquire Cellavista Systems Business From Roche ............................................................................................ 95
          Acquisition .................................................................................................................................................................................... 96
             Roche Completes Acquisition Of Verum Diagnostica For $15 Million ....................................................................................... 96
             Roche Completes Acquisition Of mtm Labs .............................................................................................................................. 97
             Roche Completes Acquisition Of PVT Probenverteiltechnik And PVT Lab Systems For $126.14 Million ................................. 99
             Ventana Medical Systems Acquires BioImagene .................................................................................................................... 100
             Roche Holding Acquires Medingo From Elron Electronic Industries ....................................................................................... 102
             Roche Diagnostics Acquires Swisslab .................................................................................................................................... 104
             Roche Acquires Ventana Medical Systems............................................................................................................................. 105
             Ventana Medical Acquires Spring Bioscience ......................................................................................................................... 107
F. Hoffmann-La Roche Ltd. - Medical Equipment - Deals and                                                                                                              Reference Code: GDME756D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 3
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
             Roche Acquires BioVeris......................................................................................................................................................... 108
             Roche Acquires 454 Life Sciences From CuraGen ................................................................................................................. 110
       F. Hoffmann-La Roche Ltd. - Key Competitors............................................................................................................................... 111
       Key Employees .............................................................................................................................................................................. 112
       Locations And Subsidiaries ............................................................................................................................................................ 113
          Head Office ................................................................................................................................................................................. 113
          Other Locations & Subsidiaries ................................................................................................................................................... 113
       Recent Developments .................................................................................................................................................................... 119
          Strategy And Business Planning................................................................................................................................................. 119
             Dec 07, 2012: Roche Opens New Sales Headquarters In Chengdu, China............................................................................ 119
             Sep 05, 2012: Roche Provides Update On Its Strategy At Investor Conference ..................................................................... 119
             Jun 26, 2012: Roche To Shut New Jersey Site, Eliminate 1,000 Jobs .................................................................................... 119
             Mar 05, 2012: Roche Selects ICON As Technology Partner ................................................................................................... 120
          Financial Announcements........................................................................................................................................................... 121
             Jan 30, 2013: Roche Reports Group Sales Of CHF45.5 Billion In 2012 ................................................................................. 121
             Oct 16, 2012: Roche Reports Group Sales Of CHF33.7 Billion For Nine Months Ended September 30, 2012 ...................... 122
             Jul 26, 2012: Roche Reports Group Sales Of CHF22.4 Billion In H1 2012 ............................................................................. 124
             Apr 12, 2012: Roche Reports Group Sales Of CHF11 Billion In Q1 2012 ............................................................................... 126
             Feb 01, 2012: Roche Reports Sales Of CHF42.5 Billion In 2011 ............................................................................................ 127
          Research And Development ....................................................................................................................................................... 128
             Feb 22, 2013: Research Consortium Announces Significant Progress To Close Gaps And Uncover New Genes In Human
             Reference Genome Sequence ................................................................................................................................................ 128
          Corporate Communications ........................................................................................................................................................ 128
             Mar 05, 2013: Roche's Chairman Franz Humer To Resign..................................................................................................... 128
             Aug 28, 2012: Roche Announces Senior Management Changes ........................................................................................... 128
             Jun 26, 2012: Roche To Shut New Jersey Site, Eliminate 1,000 Jobs.................................................................................... 129
          Legal and Regulatory .................................................................................................................................................................. 130
             Feb 28, 2013: The Red Cross Blood Transfusion Service of Upper Austria Obtains Accreditation For New Tissue Typing
             Method For Stem Cell Transplants .......................................................................................................................................... 130
             Mar 13, 2012: Roche Receives Request For Additional Information From FTC...................................................................... 130
          Government and Public Interest .......................................................
				
DOCUMENT INFO
Description: F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company. It discovers, develops, manufactures and markets innovative diagnostics and therapeutic products and services. The company classified its operations into two reportable business segments, namely, Pharmaceuticals and Diagnostics. Roche's products and services address the prevention, diagnosis and treatment of diseases, and improve the well-being and quality of life of patients. Geographically, the company has operations in various countries across North America, Latin America, Europe and Asia. Roche is headquartered in Basel, Switzerland.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.